|1.||Mourão, Paulo A S: 9 articles (05/2015 - 01/2004)|
|2.||Fonseca, Roberto J C: 5 articles (05/2015 - 12/2006)|
|3.||Pavão, Mauro S G: 3 articles (01/2014 - 05/2007)|
|4.||Leite, Maurilo: 2 articles (01/2014 - 12/2010)|
|5.||Takiya, Christina M: 2 articles (01/2014 - 12/2010)|
|6.||Mourão, P A: 2 articles (09/2000 - 08/2000)|
|7.||Tomaz, Marcelo A: 1 article (05/2015)|
|8.||Strauch, Marcelo A: 1 article (05/2015)|
|9.||Borges, Paula A: 1 article (05/2015)|
|10.||Patrão-Neto, Fernando C: 1 article (05/2015)|
11/01/2013 - "In this study, we investigated the improvement of fucosylated chondroitin sulfate (CHS) from the cucumber Acaudina molpadioides on hyperglycemia in skeletal muscle of insulin resistant mice. "
11/01/2013 - "Fucosylated chondroitin sulfate from Acaudina molpadioides improves hyperglycemia via activation of PKB/GLUT4 signaling in skeletal muscle of insulin resistant mice."
11/01/2009 - "In contrast, fucosylated chondroitin sulfate is significantly more potent than sulfated fucan in arterial thrombosis. "
12/01/2006 - "We have shown that intravascular injection of fucosylated chondroitin sulfate inhibits thrombus formation in a venous and an arterial shunt model in rats. "
01/01/2004 - "Sulfated alpha-L-fucans and fucosylated chondroitin sulfate also express antithrombotic activity when tested on in vivo models of venous and arterial thrombosis in experimental animals. "
01/01/2004 - "The carboxyl-reduced derivative of fucosylated chondroitin sulfate prevented thrombosis in the arterio-venous shunt, but not in the venous experimental model. "
01/01/2004 - "The action of fucosylated chondroitin sulfate on thrombosis is apparently unrelated to its effect on platelet aggregation. "
|3.||Venous Thrombosis (Deep-Vein Thrombosis)
11/01/2009 - "For instance, the sulfated fucan inhibits venous thrombosis at lower doses than fucosylated chondroitin sulfate. "
05/01/2010 - "When tested using a venous thrombosis experimental model, oversulfated chondroitin sulfate is less potent as an antithrombotic agent than fucosylated chondroitin sulfate. "
01/01/2004 - "We propose that the different effects of fucosylated chondroitin sulfate and its carboxyl-reduced derivative on venous thrombosis may be related to adherence of the glycosaminoglycan to the vessel wall."
11/01/2009 - "Finally, fucosylated chondroitin sulfate increases bleeding, while sulfated fucan has only a discrete effect. "
01/01/2004 - "We have now compared the anticoagulant, bleeding and antithrombotic effects of this fucosylated chondroitin sulfate and its carboxyl-reduced derivative. "
11/01/2009 - "We tested the effects of two of these polysaccharides, namely a sulfated fucan and a fucosylated chondroitin sulfate, on coagulation, thrombosis and bleeding. "
01/01/2014 - "Among the glycans studied are low-sulfated heparin-like polymers from ascidians, containing significant anticoagulant activity and no bleeding effect; dermatan sulfates with significant neurite outgrowth promoting activity and anti-P-selectin from ascidians, and a unique fucosylated chondroitin sulfate from sea cucumbers, possessing anticoagulant activity after oral administration and high anti P- and L-selectin activities. "
|5.||Wounds and Injuries (Trauma)
|6.||Chondroitin Sulfates (Chondroitin Sulfate)
|10.||Sulfates (Sulfates, Inorganic)